Brandywine Global Investment Management LLC trimmed its position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Free Report) by 1.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 132,995 shares of the specialty pharmaceutical company’s stock after selling 1,576 shares during the quarter. Brandywine Global […]